Sandu Pharmaceuticals Limited (BOM:524703)

Sandu Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	696.24	699.35	671.92	672.81	653.49	655.01
Revenue Growth	4.16%	4.08%	-0.13%	2.96%	-0.23%	11.48%
Gross Profit Gross Profit Growth	403.46	363.1	329.57	326.41	320.66	276.7
Operating Income Operating Income Growth	23.49	23.23	20.92	17.12	19.69	23.44
Net Income Net Income Growth	17.71	17.66	15.49	14.61	15.21	15.89
Earnings Per Share EPS Growth	2.02	1.83	1.60	1.51	1.61	1.87
EPS Growth	21.50%	14.26%	5.96%	-6.21%	-13.90%	21.43%

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	68.56	68.56	26.53	12.06	22.96	41.71
Total Debt Total Debt Growth	4.19	4.19	4.78	0.63	-	-
Net Cash (Debt) Net Cash Growth	64.37	64.37	21.76	11.43	22.96	41.71
Net Cash Growth	195.87%	195.87%	90.33%	-50.21%	-44.96%	-64.16%
Net Cash Per Share Net Cash Per Share Growth	7.34	6.66	2.25	1.18	2.43	4.91

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	-	61.16	9.5	7.6	2.21	9.49
Capital Expenditures CapEx Growth	-	-7.2	-9.38	-14.25	-10.69	-8.41
Free Cash Flow Free Cash Flow Growth	-	53.96	0.12	-6.65	-8.48	1.08
Free Cash Flow Growth	-	43412.10%	-	-	-	-98.56%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	57.95%	51.92%	49.05%	48.51%	49.07%	42.24%
Operating Margin	3.37%	3.32%	3.11%	2.54%	3.01%	3.58%
Pretax Margin	3.85%	3.80%	3.21%	3.08%	3.39%	3.54%
Profit Margin	2.54%	2.53%	2.31%	2.17%	2.33%	2.43%
FCF Margin	-	7.71%	0.02%	-0.99%	-1.30%	0.16%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	1.000	1.000	0.800	0.800	0.750	0.750
Dividend Per Share Growth	25.00%	25.00%	0%	6.67%	0%	50.00%
Dividend Yield	2.62%	3.36%	1.70%	1.47%	1.53%	1.15%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 7, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	18.92	16.69	30.56	37.94	39.01	39.00
P/FCF Ratio	6.84	5.47	3816.87	-	-	575.52
PS Ratio	0.53	0.42	0.70	0.82	0.91	0.95

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error